Acasti Pharma reported $-2.45M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Acasti Pharma USD -2.45M 735K Dec/2025
Addus HomeCare USD 50.34M 5.19M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
Cassava Sciences USD -11.73M 33.44M Sep/2025
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Option Care Health USD 126M 6.5M Dec/2025
Organigram Holdings CAD 5.26M 884K Dec/2025
Tilray USD 8.36M 1.82M Sep/2025